Northwest Financial Advisors Cassava Sciences Inc Transaction History
Northwest Financial Advisors
- $136 Billion
- Q1 2024
A detailed history of Northwest Financial Advisors transactions in Cassava Sciences Inc stock. As of the latest transaction made, Northwest Financial Advisors holds 1,089 shares of SAVA stock, worth $13,971. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,089
Previous 1,089
-0.0%
Holding current value
$13,971
Previous $24.5 Million
9.86%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
172Shares Held
11.3MCall Options Held
1.61MPut Options Held
1.43M-
Black Rock Inc. New York, NY3.05MShares$39.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$30.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.09MShares$14 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA902KShares$11.6 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO585KShares$7.51 Million6.03% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $514M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...